Blau Farmacêutica S.A., a pharmaceutical company provides private label drugs in Brazil, Argentina, Colombia, the United States, Ecuador, Peru, and Uruguay. The company's medications cover various therapeutic classes, such as immunology, hematology, oncology, nephrology, specialties, and antibiotics. It also offers biological drugs; oral and injectable drugs for treating cancer; specialized treatments for infectious diseases; and prescription and non-prescription drugs, including dermo-medicines, condoms, and others for retail and non-retail markets. In addition, the company provides blood-derived, biological, biotechnological, and antiretroviral drugs. It serves hospitals, private clinics, chemotherapy and hemodialysis centers, and public health institutions. The company was incorporated in 1987 and is headquartered in Cotia, Brazil.
Blau Farmacêutica Dividend Announcement
• Blau Farmacêutica announced a quarterly dividend of R$0.08 per ordinary share which will be made payable on 2024-12-31. Ex dividend date: 2024-09-27
• Blau Farmacêutica annual dividend for 2024 was R$0.36
• Blau Farmacêutica annual dividend for 2023 was R$0.42
• Blau Farmacêutica's trailing twelve-month (TTM) dividend yield is 2.39%
• Blau Farmacêutica's payout ratio for the trailing twelve months (TTM) is 36.38%
Blau Farmacêutica Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-09-27 | R$0.08 | quarterly | 2024-12-31 |
2024-06-27 | R$0.14 | quarterly | 2024-07-10 |
2024-04-30 | R$0.01 | quarterly | 2024-12-01 |
2024-03-25 | R$0.13 | quarterly | |
2023-06-28 | R$0.19 | quarterly | 2023-10-30 |
2023-04-20 | R$0.05 | quarterly | 2023-12-22 |
2023-03-27 | R$0.18 | quarterly | 2023-04-17 |
2022-12-22 | R$0.18 | quarterly | 2022-12-29 |
2022-09-27 | R$0.17 | quarterly | 2022-10-17 |
2022-07-08 | R$0.16 | quarterly | 2022-07-15 |
2022-04-08 | R$0.14 | quarterly | 2022-04-19 |
2022-03-25 | R$0.21 | quarterly | 2022-04-05 |
2021-12-06 | R$0.12 | quarterly | 2021-12-15 |
2021-09-24 | R$0.11 | quarterly | 2021-10-05 |
2021-07-06 | R$0.02 | quarterly | 2021-07-15 |
Blau Farmacêutica Dividend per year
Blau Farmacêutica Dividend growth
Blau Farmacêutica Dividend Yield
Blau Farmacêutica current trailing twelve-month (TTM) dividend yield is 2.39%. Interested in purchasing Blau Farmacêutica stock? Use our calculator to estimate your expected dividend yield:
Blau Farmacêutica Financial Ratios
Blau Farmacêutica Dividend FAQ
Other factors to consider when evaluating Blau Farmacêutica as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Blau Farmacêutica stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Blau Farmacêutica's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Blau Farmacêutica publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Blau Farmacêutica distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Blau Farmacêutica are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Blau Farmacêutica sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Blau Farmacêutica distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Blau Farmacêutica declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Blau Farmacêutica's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Blau Farmacêutica's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.